Schuetz Philipp
Department of Endocrinology, Diabetes and Clinical Nutrition, University Department of Internal Medicine, Kantonsspital Aarau and Medical Faculty, University of Basel Switzerland, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.
BMC Med. 2017 Feb 24;15(1):38. doi: 10.1186/s12916-017-0812-x.
Although clinical nutrition is a frequently used intervention in inpatient care, high quality trials proving its effectiveness and safety when used in the acutely-ill polymorbid medical inpatient population are largely lacking. From an evolutionary perspective, illness-related low appetite is protective and part of the host response to improve recovery from disease. Large and well performed trials in the intensive care setting have shown deleterious effects of (parenteral) feeding strategies aiming at higher caloric intakes compared to lower intakes, raising the question of whether feeding per se may be simply maladaptive in acute severe illness. Outside critical care, similar large-scale studies are lacking with basic clinical questions regarding the optimal amount/composition of nutrition and best patient selection remaining largely unanswered. Also, the interplay of nutritional interventions and its influence on the microbiome remains largely unclear. Given the magnitude of morbidity caused by malnutrition and the high number of affected patients, it is surprising how little the medical community has invested in better understanding ways to improve this condition. It is now time to perform high-quality trials to better understand how to best deal with this condition in the acute care setting. Such trials will allow change from a one-size-fits-all approach, to more evidence-based, personalized nutritional interventions, ultimately improving patient outcomes. While there is ongoing discussion about definition of malnutrition, we should rather focus on the identification of patients who do or do not benefit from nutritional interventions.
尽管临床营养是住院治疗中常用的干预措施,但在急性病多发的内科住院患者中,证明其有效性和安全性的高质量试验却十分匮乏。从进化的角度来看,疾病相关的食欲减退具有保护作用,是机体为促进疾病康复而产生的反应的一部分。在重症监护环境中开展的大型且执行良好的试验表明,与低热量摄入的(肠外)喂养策略相比,高热量摄入的喂养策略具有有害影响,这就引发了一个问题:在急性重症疾病中,喂养本身是否可能只是一种适应不良的行为。在重症监护之外,缺乏类似的大规模研究,关于营养的最佳量/组成以及最佳患者选择等基本临床问题在很大程度上仍未得到解答。此外,营养干预与微生物群之间的相互作用在很大程度上也不清楚。鉴于营养不良导致的发病率之高以及受影响患者数量众多,令人惊讶的是,医学界在更好地理解改善这种状况的方法上投入如此之少。现在是时候开展高质量试验了,以便更好地了解在急性护理环境中如何最好地应对这种状况。此类试验将促使从一刀切的方法转变为更基于证据的个性化营养干预,最终改善患者的治疗效果。虽然关于营养不良的定义仍在持续讨论,但我们更应专注于识别哪些患者能从营养干预中获益,哪些不能。